Price T Rowe Associates Inc Ocugen, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 235,860 shares of OCGN stock, worth $214,632. This represents 0.0% of its overall portfolio holdings.

Number of Shares

235,860

Previous 268,820 12.26%

Holding current value

$214,632

Previous $417,000 43.65%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.98 - $1.95 $32,300 - $64,272	-32,960 Reduced 12.26%	235,860 $235,000
Q2 2024 Aug 14, 2024	BUY	$1.18 - $1.98 $96,429 - $161,805	81,720 Added 43.68%	268,820 $417,000
Q4 2023 Feb 14, 2024	BUY	$0.36 - $0.57 $33,480 - $53,009	93,000 Added 98.83%	187,100 $108,000
Q3 2023 Nov 14, 2023	BUY	$0.4 - $0.62 $25,120 - $38,936	62,800 Added 200.64%	94,100 $38,000
Q2 2023 Aug 14, 2023	SELL	$0.45 - $0.88 $61,651 - $120,562	-137,003 Reduced 81.4%	31,300 $17,000
Q1 2023 May 15, 2023	BUY	$0.82 - $1.33 $3,748 - $6,079	4,571 Added 2.79%	168,303 $144,000
Q4 2022 Feb 14, 2023	BUY	$1.11 - $1.87 $29,870 - $50,321	26,910 Added 19.67%	163,732 $213,000
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.1 $22,400 - $39,680	12,800 Added 10.32%	136,822 $244,000
Q2 2022 Aug 15, 2022	SELL	$1.83 - $3.45 $11,382 - $21,459	-6,220 Reduced 4.78%	124,022 $282,000
Q1 2022 May 16, 2022	BUY	$2.34 - $4.72 $6,105 - $12,314	2,609 Added 2.04%	130,242 $430,000
Q4 2021 Feb 14, 2022	BUY	$4.38 - $15.67 $94,502 - $338,095	21,576 Added 20.34%	127,633 $581,000
Q3 2021 Nov 15, 2021	BUY	$6.36 - $8.51 $418,488 - $559,958	65,800 Added 163.45%	106,057 $761,000
Q2 2021 Aug 16, 2021	BUY	$5.52 - $15.68 $154,322 - $438,365	27,957 Added 227.29%	40,257 $323,000
Q1 2021 May 17, 2021	BUY	$1.66 - $15.81 $20,418 - $194,463	12,300 New	12,300 $84,000

Others Institutions Holding OCGN

# of Institutions

125

Shares Held

78.3M

Call Options Held

535K

Put Options Held

523K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $197M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Ocugen, Inc. Transaction History